Anzeige
Meldung des Tages: Fusion im Wert von 1 Mrd. US-Dollar! Eine Royalty-Ausgliederung! Der Meeresboden wird neu bewertet

GenSight Biologics News

Aktie
WKN:  A2ANGZ ISIN:  FR0013183985 US-Symbol:  GSGTF Branche:  Biotechnologie Land:  Frankreich
0,0816 €
-0,0002 €
-0,24%
22:44:21 Uhr
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
68,49%
KGV
-1,80
Index-Zuordnung
-

GenSight Biologics News

28.04.26 - Businesswire
GenSight Biologics Announces Annual General Meeting to Take Place on May 19, 2026
Regulatory News:
15.04.26 - Businesswire
GenSight Biologics Announces the Filing of its 2025 Universal Registration Document
Regulatory News:
07.04.26 - Businesswire
GenSight Biologics Reports Cash Position and Revenue from Early Access Program as of March 31, 2026
Regulatory News:
03.04.26 - Businesswire
GenSight Biologics Confirms Definitive Full-Year 2025 Consolidated Financial Results Are in Line with Estimates
Regulatory News:
27.03.26 - Businesswire
GenSight Biologics Reports Estimated Full-Year Consolidated Financial Results for 2025
Regulatory News:
20.03.26 - Businesswire
The 15-20 National Hospital and GenSight Biologics Announce the First Treatments in the French Named Patient Early Access Program (AAC) for GS010/LUMEVOQ®
Regulatory News:
18.03.26 - Businesswire
GenSight Biologics Announces the Closing of its Nearly €1.7 Million Fundraising
Regulatory News:
10.03.26 - Businesswire
GenSight Biologics Announces Successful Fundraising Worth Nearly €1.7 Million
Regulatory News:
09.03.26 - Businesswire
GenSight Biologics Provides Updates about GS010/LUMEVOQ® Early Access Programs and the Ongoing REVISE Study
Regulatory News:
18.02.26 - Businesswire
GenSight Biologics Bolsters Regulatory Leadership in US and Europe with Two Senior Appointments
Regulatory News:
10.02.26 - Businesswire
The 15-20 National Hospital and GenSight Biologics Announce the Treatment of the First Patient in the GS010/LUMEVOQ® REVISE Study
Regulatory News:

Newssuche

Videos

newspaper
26.04.26
Big Fish Strategy Einführung
Strategie-​Paket inklusive Live-​Webinar am 3.5., Videoaufzeichnung, Unterlagen und Nachbetreuung JETZT ... Mehr »